药物对比
Fremanezumab vs Atogepant
Compare Fremanezumab (Ajovy) injectable CGRP mAb vs Atogepant (Qulipta) oral gepant for migraine prevention. Differences in route, dosing, and side effects.
此页面暂无可用的对比维度。
临床背景
This comparison typically arises for patients choosing between injectable CGRP antibodies and oral gepants for migraine prophylaxis.
结论
Both Fremanezumab and Atogepant are effective CGRP therapies for migraine prevention with the choice driven by administration preference.
全部药物对比